Health knowledge made personal
WellPage for Inhalation Solution
+ Bookmark › Share
Go
Search posts:

Inhalation Solution - Articles

FDA Warns Consumers Not to Use Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution by Health: Hearsay & Headlines Posted Tue 13 Oct 2009 10:04pm The U.S. Food and Drug Administration today advised consumers not to use certain respiratory medications purchased after Sept. 8, 2009 and manufactured by Dey L.P., a subsidiary of Mylan Inc., because the medications might have been part of a shipment being transported on a tractor-trailer stolen in Tampa, Fla., on Sept. 8, 2009. The respirato ... Read on »
Warning on Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution by FDA Posted Thu 22 Aug 2013 3:49pm On September 17, 2009, the U.S. Food and Drug Administration (FDA) advised consumers not to use certain respiratory medications purchased after Sept. 8, 2009 and manufactured by Dey L.P., a subsidiary of Mylan Inc., because the medications might have been part of a shipment being transported on a tractor-trailer stol ... Read on »
The Ritedose Corporation Announces the Voluntary Nationwide Recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL Due to by FDA Posted Mon 03 Jan 2011 10:27am FOR IMMEDIATE RELEASE - December 30, 2010 - The Ritedose Corporation is conducting a voluntary recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL (in 25, 30, and 60 unit dose vials). This product is a prescription inhalation solution, administered via nebulization, for the treatment and maintenance of acute asthma exa ... Read on »
Albuterol Sulfate Inhalation Solution 0.083%, 3 mL Unit Dose Vials: Recall - Mislabeled Unit Dose Vials by FDA Posted Mon 03 Jan 2011 3:20pm [Posted 01/03/2011] AUDIENCE: Family Practice, Pharmacy, Consumer ISSUE: The Ritedose Corporation is conducting a voluntary recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25, 30, and 60 unit dose vials. This product is being recalled because the 2.5 mg/3 mL single use vials are embossed with the w ... Read on »
Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results by FDA Posted Thu 17 Oct 2013 3:30pm [Posted 10/17/2013] AUDIENCE: Pharmacy ISSUE: Nephron Pharmaceuticals initiated a voluntary recall, at the retail level, of ten lots of product due to results from an internal monitoring process. NPC performs aseptic process simulation as part of an internal processes to assure product quality. A ... Read on »
Current Drug Shortages: Acetylcysteine Inhalation Solution (updated) by Health & Human Services Posted Tue 14 Aug 2012 1:09pm Hospira: 100 mg/mL; 30 mL vial (NDC 0409-3307-03), Next delivery October. 200 mg/mL; 30 mL vial (NDC 0409-3308-03), Next delivery November. Read on »
Nephron Pharmaceuticals Corporation Announces Voluntary Recall of Albuterol Sulfate Inhalation Solution, 0.083% by FDA Posted Thu 17 Oct 2013 10:55am Nephron Pharmaceuticals Corporation (NPC) has initiated a voluntary recall, at the retail level, as a precautionary measure, due to results from our internal monitoring processes. NPC is asking retailers to remove the affected lots from store shelves and is asking consumers to discontinue use and dispose of any product they may have that is incl ... Read on »
Inspire Pharmaceuticals by Nathan L. Patient Expert Posted Sat 23 Aug 2008 11:37pm The annual CFF Meeting that Tricia and I attended last week took place at Inspire Pharmaceuticals, Inc. which recently initiated a second Phase 3 clinical trial evaluating denufosol tetrasodium inhalation solution for the treatment of Cystic Fibrosis. A few of the Inspire doctors/scientists spent several minutes explaining this new drug. ... Read on »
FDA Approves Hypertension Drug (with Conditions) that You Inhale - Tyvaso by Medical Quack Patient ExpertHealth Maven Posted Fri 31 Jul 2009 10:18am This is more than just a drug, it is a drug and a delivery system technically.  More and more I seem to be seeing more drugs steering towards an inhalable formula.  This is not the first one as there are others on the market.  The first one that everyone seems to remember was the “huge” giant inhaler which is no longer available from Pfizer, it l ... Read on »
Teva Announces FDA Approval of Inhaled Antibiotic Tobramycin by Medical Quack Patient ExpertHealth Maven Posted Mon 14 Oct 2013 10:09pm The generic version should be launched in late November.  Tobramycin is an antibiotic drug used to fight bacterial infections.  It is currently marketed under the names of Tobrex or Tobi.  The drug is inhaled into the lungs using a nebulizer.  A 28 day supply costs $2400, wow so there’s a ton of room for savings here.  Tev ... Read on »